- HC Wainwright & Co. lowered the price target for Arcturus Therapeutics Holdings Inc ARCT from $84 to $50. Arcturus Therapeutics shares fell 33.6% to $61.29 in pre-market trading.
- RBC Capital cut Aprea Therapeutics Inc APRE price target from $40 to $10. Aprea Therapeutics shares rose 2.6% to $5.64 in pre-market trading.
- Baird lowered Arcturus Therapeutics Holdings Inc ARCT price target from $79 to $69. Arcturus Therapeutics shares fell 33.6% to $61.29 in pre-market trading.
- Raymond James raised Wells Fargo & Co WFC price target from $32 to $35. Wells Fargo shares rose 0.6% to $30.12 in pre-market trading.
- Credit Suisse boosted the price target on Cognizant Technology Solutions Corp CTSH from $79 to $91. Cognizant Technology shares closed at $81.37 on Monday.
- Goldman Sachs raised Snap Inc SNAP price target from $47 to $70. Snap shares rose 6% to $51.15 in pre-market trading.
- Credit Suisse cut the price target on Lantheus Holdings Inc LNTH from $16 to $14. Lantheus shares rose 0.4% to close at $14.80 on Monday.
APREAprea Therapeutics Inc
$2.3110.5%
Edge Rankings
Momentum10.56
Growth-
Quality-
Value-
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
